6ix — Find Your Next Investment

Discover investor relations events, company profiles, and opportunities on 6ix. Connect with public companies and attend live investor events.

Please enable JavaScript to use all features of 6ix.com.

Original text

Rate this translation

Your feedback will be used to help improve Google Translate

Latest Press Releases

Time	Headline
1h ago	Elektros Inc. Unveils Transformational Lithium Opportunity and Breakthrough EV Charging Patent at a Compelling Market Entry Point
2h ago	Dollar Tree Named Entitlement Sponsor for New England's Only NASCAR Cup Series Race
10h ago	Planet Launches Three Additional High-Resolution Pelican Satellites
14h ago	EgyptAir Takes Delivery of First Boeing 737 MAX Jet
18h ago	Elektros Ignites a New Era of Profit in Energy: Breakthrough 'Energy Core' Platform Positions Investors to Capture Massive Upside Amid Historic Utility Cost Surge

About

Pharmala Biotech Holdings, Inc. — investor relations, events, news, and company updates on 6ix.

Latest News

PharmAla Executes Binding Letter of Intent for Formation of Special Purpose Vehicle to Develop Patented Novel MDXX Molecule APA-01

PharmAla Issues Q2 Financial Statements and Grants Options

PharmAla Biotech Positioned to Supply U.S. Expanded Access Pathway for MDMA Established by Presidential Executive Order

PharmAla Signs Supply & Data Agreement with Nautilus Sanctuary for Phase 2 MDMA Clinical Trial Treating Post-Traumatic Stress and Adjustment Disorder in Frontline Healthcare Workers and First Responders

PharmAla Signs Drug Donation Agreement for MDMA-Assisted Therapy Clinical Trial in Fibromyalgia

How Pharmala Biotech Holdings, Inc. runs its investor program on 6ix — audience, formats, and program overview.

Recent Videos

PharmAla CEO joins veterans urging action to make psychedelic therapies accessible in Canada.

PharmAla CEO joins veterans urging action to make psychedelic therapies accessible in Canada.

Oct 23, 2025

PharmAla Biotech Holdings Inc. (CSE: MDMA | OTCQB: MDXXF): Virtual Investor Conferences

PharmAla Biotech Holdings Inc. (CSE: MDMA | OTCQB: MDXXF): Virtual Investor Conferences

Oct 16, 2025

PharmAla Biotech drives clinical MDMA development, targets neuropathic pain and brain trauma

PharmAla Biotech drives clinical MDMA development, targets neuropathic pain and brain trauma

Oct 15, 2025

PhenSafe Ai Announcement

PhenSafe Ai Announcement

Jul 30, 2025

Community Chat

Ask AI